Ken Yoshimura

542 total citations
31 papers, 368 citations indexed

About

Ken Yoshimura is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Ken Yoshimura has authored 31 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Infectious Diseases. Recurrent topics in Ken Yoshimura's work include Kawasaki Disease and Coronary Complications (11 papers), Coronary Artery Anomalies (6 papers) and Cardiac Structural Anomalies and Repair (4 papers). Ken Yoshimura is often cited by papers focused on Kawasaki Disease and Coronary Complications (11 papers), Coronary Artery Anomalies (6 papers) and Cardiac Structural Anomalies and Repair (4 papers). Ken Yoshimura collaborates with scholars based in Japan, Portugal and Bangladesh. Ken Yoshimura's co-authors include Kazunari Kaneko, Shoji Tsuji, Takahisa Kimata, Masayuki Teraguchi, Haruo Watanabe, Akihiro Yasuhara, Atsushi Ohashi, Hidemasa Izumiya, Takamichi Uchiyama and Hirotaro Ogino and has published in prestigious journals such as European Respiratory Journal, The Journal of Pediatrics and Emerging infectious diseases.

In The Last Decade

Ken Yoshimura

31 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Yoshimura Japan 12 186 166 48 48 42 31 368
Meng-Luen Lee Taiwan 10 103 0.6× 154 0.9× 42 0.9× 57 1.2× 28 0.7× 51 304
Albert Yick Hou Lim Singapore 16 69 0.4× 258 1.6× 80 1.7× 17 0.4× 7 0.2× 54 505
Zhong Chen China 11 148 0.8× 92 0.6× 44 0.9× 43 0.9× 5 0.1× 39 322
Melih Hulusi Us Türkiye 9 151 0.8× 62 0.4× 38 0.8× 86 1.8× 4 0.1× 39 299
N Khrouf Tunisia 10 63 0.3× 68 0.4× 38 0.8× 28 0.6× 3 0.1× 34 320
Bülent Sıvrı Türkiye 15 226 1.2× 59 0.4× 51 1.1× 24 0.5× 32 0.8× 39 498
Dita Aditianingsih Indonesia 10 127 0.7× 72 0.4× 44 0.9× 26 0.5× 4 0.1× 37 399
Konstantinos Kollios Greece 13 69 0.4× 53 0.3× 32 0.7× 48 1.0× 3 0.1× 36 399
Supratim Sen India 8 113 0.6× 99 0.6× 26 0.5× 33 0.7× 15 0.4× 18 268
Albert D. Yang Taiwan 12 291 1.6× 94 0.6× 7 0.1× 14 0.3× 28 0.7× 30 427

Countries citing papers authored by Ken Yoshimura

Since Specialization
Citations

This map shows the geographic impact of Ken Yoshimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Yoshimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Yoshimura more than expected).

Fields of papers citing papers by Ken Yoshimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Yoshimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Yoshimura. The network helps show where Ken Yoshimura may publish in the future.

Co-authorship network of co-authors of Ken Yoshimura

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Yoshimura. A scholar is included among the top collaborators of Ken Yoshimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Yoshimura. Ken Yoshimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hori, Shinichiro, et al.. (2022). L‐carnitine rescue for neonatal intractable mitochondrial cardiomyopathy. Pediatrics International. 64(1). e15143–e15143. 1 indexed citations
2.
Sakib, Najmuj, A. K. M. Israfil Bhuiyan, Mohammed A. Mamun, et al.. (2021). Distribution of β-Thalassemia and Other Hemoglobinopathies in Bangladeshi University Students and Ready-Made Garment Workers. Risk Management and Healthcare Policy. Volume 14. 2707–2714. 3 indexed citations
3.
Hori, Shinichiro, et al.. (2021). Combined Single Nucleotide Variants of ORAI1 and BLK in a Child with Refractory Kawasaki Disease. Children. 8(6). 433–433. 1 indexed citations
4.
Hossain, Moazzem, et al.. (2020). Management of Lymphatic Filariasis with Impact on Morbidity Control in Bangladesh. 4(2). 1 indexed citations
5.
Kimata, Takahisa, Sohsaku Yamanouchi, Shoji Tsuji, et al.. (2017). Risk factors for sodium valproate-induced renal tubular dysfunction. Clinical and Experimental Nephrology. 22(2). 420–425. 5 indexed citations
6.
Kato, Shogo, et al.. (2015). Urinary 8-Hydroxy-2′-Deoxyguanosine: A Biomarker for Radiation-Induced Oxidative DNA Damage in Pediatric Cardiac Catheterization. The Journal of Pediatrics. 167(6). 1369–1374.e1. 13 indexed citations
7.
Kaneko, Kazunari, Ken Yoshimura, & Shoji Tsuji. (2014). Brain Natriuretic Peptide as a Novel Diagnostic Biomarker in Kawasaki Disease. Journal of Comprehensive Pediatrics. 5(4). 3 indexed citations
8.
Kato, Shogo, Ken Yoshimura, Yuko Tanabe, et al.. (2013). A Child With Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis Complicated by Coronary Artery Lesion Mimicking Kawasaki Disease. Journal of Pediatric Hematology/Oncology. 35(7). e317–e319. 11 indexed citations
9.
Yoshimura, Ken, et al.. (2013). N-Terminal Pro-Brain Natriuretic Peptide and Risk of Coronary Artery Lesions and Resistance to Intravenous Immunoglobulin in Kawasaki Disease. The Journal of Pediatrics. 162(6). 1205–1209. 31 indexed citations
10.
Ogino, Hirotaro, Kazunari Kaneko, Takamichi Uchiyama, et al.. (2012). Risk of coronary arterial lesions in immunoglobulin resistant Kawasaki disease. Open Journal of Pediatrics. 2(1). 38–41. 1 indexed citations
11.
Kimata, Takahisa, Shoji Tsuji, Ken Yoshimura, Hiroyasu Tsukaguchi, & Kazunari Kaneko. (2012). Methicillin-resistant Staphylococcus aureus-related glomerulonephritis in a child. Pediatric Nephrology. 27(11). 2149–2152. 4 indexed citations
12.
Kaneko, Kazunari, Masaya Takahashi, Ken Yoshimura, et al.. (2012). Intravenous Immunoglobulin Counteracts Oxidative Stress in Kawasaki Disease. Pediatric Cardiology. 33(7). 1086–1088. 15 indexed citations
13.
Teraguchi, Masayuki, Hirotaro Ogino, Ken Yoshimura, et al.. (2012). Steroid Pulse Therapy for Children With Intravenous Immunoglobulin Therapy–Resistant Kawasaki Disease: A Prospective Study. Pediatric Cardiology. 34(4). 959–963. 30 indexed citations
14.
Kaneko, Kazunari, et al.. (2010). Immunoglobulin preparations affect hyponatremia in Kawasaki disease. European Journal of Pediatrics. 169(8). 957–960. 5 indexed citations
15.
Fuji, Shigeo, Shunsuke Mori, Ken Yoshimura, et al.. (2009). Intensive glucose control after allogeneic hematopoietic stem cell transplantation: a retrospective matched-cohort study. Bone Marrow Transplantation. 44(2). 105–111. 26 indexed citations
16.
Yoshimura, Ken, et al.. (2008). Increased nitric oxide production by neutrophils in early stage of Kawasaki disease. European Journal of Pediatrics. 168(9). 1037–1041. 32 indexed citations
17.
Takaya, Junji, Masayuki Teraguchi, Yumiko Ikemoto, et al.. (2006). Turner Syndrome Associated with Ulcerative Colitis. Clinical Pediatric Endocrinology. 15(3). 97–100. 1 indexed citations
18.
Ikemoto, Yumiko, et al.. (2003). Serial changes of plasma nitrate in the acute phase of Kawasaki disease. Pediatrics International. 45(4). 421–425. 7 indexed citations
19.
Yasuhara, Akihiro, et al.. (2003). Life-Threatening Infantile Diarrhea from Fluoroquinolone-ResistantSalmonella entericTyphimurium with Mutations in BothgyrAandparC. Emerging infectious diseases. 9(2). 255–257. 50 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meng-Luen Lee Breakdown of academic impact, for papers by Albert Yick Hou Lim Breakdown of academic impact, for papers by Zhong Chen Breakdown of academic impact, for papers by Melih Hulusi Us Breakdown of academic impact, for papers by N Khrouf Breakdown of academic impact, for papers by Bülent Sıvrı Breakdown of academic impact, for papers by Dita Aditianingsih Breakdown of academic impact, for papers by Konstantinos Kollios Breakdown of academic impact, for papers by Supratim Sen Breakdown of academic impact, for papers by Albert D. Yang
Rankless by CCL
2026